Skip to main content
ConductScienceScienceDex

ScienceDex / Researcher record

James E Galvin

From the FY2025 NIH awards this investigator leads as contact PI. The department is the award's.

FY2025 NIH rank #98
Unclaimed recordClaim profile
  • Top 1% Funded
  • Program Leader
  • R01 Holder
  • Multi-Institutional
  • Early Career
  • Mentor

NIH Funding · FY2025

Linked Award Amount
$20.4M
Full award amounts, FY2025
Award Records
6
Records listing this PI
Award-Linked Rank
#98
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2024$15,380,7848#170
2025$20,438,0636#98
2026$8,538,7855#1,132

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY20248 records
  2. FY2025 · selected6 records
  3. FY20265 records

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for James E Galvin. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 2085729Search this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.

FY2026 award categories

  • Neurology

FY2025 award records by amount

NIH award records listing James E Galvin as a PI. Multi-PI records show the full award amount for context.

  • 5R01AG080536-03R01Co-investigator
    A Phase 2b Clinical Study of the P38 Alpha Kinase Inhibitor Neflamapimod in Patients with Mild-to-Moderate Dementia with Lewy Bodies (DLB)
    Eip Pharma, Inc.
    $6.1M
    award amount
  • 1R01AG092949-01R01Co-investigator
    FDA approved IND 29644: Multicenter Phase 1 Trial to Evaluate Safety and Immunogenicity of Preventive Tau Vaccine, AV-1980R/A, in cognitively unimpaired preclinical AD participants.
    Institute for Molecular Medicine
    $5.3M
    award amount
  • 4RF1AG075904-02RF1Co-investigator
    Alzheimer's Disease and Related Dementias (ADRD) prevalence in American Samoa
    American Samoa Community Cancer Coalitio
    $4.1M
    award amount
  • 5R01AG071514-05R01Contact PI
    Multicultural Community Dementia Screening
    University of Miami School of Medicine · Neurology (NIH department code)
    $2.5M
    award amount
  • 5U01AG084528-02U01Co-investigator
    IND enabling CMC/safety/toxicology studies, submission of IND and pilot Phase 1 clinical trial with PV-1950R vaccine for Lewy Body Dementia (LBD)
    Institute for Molecular Medicine
    $1.8M
    award amount
  • 5T32AG081170-02T32Co-investigator
    Cross-disciplinary research opportunity for training in AD/ADRD science (CROSSROADS)
    University of Miami School of Medicine · Neurology (NIH department code)
    $558.7K
    award amount

Award organizations

Organizations that administered FY2025 awards listing James E Galvin as a PI.

Institute for Molecular Medicine
CA
$7.2M
2 grants
Eip Pharma, Inc.
MA
$6.1M
1 grant
American Samoa Community Cancer Coalitio
AS
$4.1M
1 grant
University of Miami School of Medicine
FL
$3.1M
2 grants

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Institute for Molecular Medicine
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    $10M Cumulative Funding
  7. 2024
    Entered Top 50% Nationally
    Ranked #170
  8. 2024
    Entered Top 25% Nationally
    Ranked #170
  9. 2024
    Entered Top 10% Nationally
    Ranked #170
  10. 2024
    Entered Top 5% Nationally
    Ranked #170
  11. 2024
    Entered Top 1% Nationally
    Ranked #170
  12. 2025
    $25M Cumulative Funding
  13. 2025
    Multi-Institutional Research
    Awards at 4 institutions
  14. 2025
    R01 Grant Holder
  15. 2025
    Program/Center Grant Leader

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as James E Galvin.

Michael G Agadjanyan
Institute for Molecular Medicine
5
shared awards
Girardin Jean-Louis
University of Miami School of Medicine
3
shared awards
John Alam
Eip Pharma, Inc.
3
shared awards
Tatjana Rundek
University of Miami School of Medicine
3
shared awards
Duygu Tosun-Turgut
Institute for Molecular Medicine
2
shared awards
Lon S Schneider
Institute for Molecular Medicine
2
shared awards
Astrid M Suchy-Dicey
University of Miami School of Medicine
1
shared award
Craig S Atwood
Weill Cornell Medicine
1
shared award
Dedra S Buchwald
University of Miami School of Medicine
1
shared award
Malaz Boustani
Indiana University Indianapolis
1
shared award

Explore further

Find collaborators for James E Galvin

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →